Roundtable on "Drug Repurposing: an unexplored and cost-effective innovation model to bring new treatment options to cancer patients quicker.” at the European Parliament on the 27th of February 2018 from 17:00 till 18:30.

The Anticancer Fund is seeking to raise awareness of the promise and value of drug repurposing in cancer treatment and to engage with key policymakers and allied stakeholders to discuss changes in the regulatory environment that would support a broader outlook for drug development and marketing, including drug repurposing. We feel now is the time to explore the topic with a broader audience and we feel the MEPs Against Cancer Group is an excellent modus with which to do this.

Read more on our lobby work